Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Feb 6;14(2):157.
doi: 10.3390/pathogens14020157.

Risk of Congenital Toxoplasmosis in Newborns from Mothers with Documented Infection: Experience from Two Referral Centres

Alice Bonetti  1   2 , Agnese Comelli  3   4 , Annacarla Chiesa  5 , Vania Spinoni  6 , Ambra Vola  1 , Federico Prefumo  7 , Adriana Valcamonico  8 , Carlo Bonfanti  9 , Silvio Caligaris  9 , Lina Rachele Tomasoni  4 , Fausto Baldanti  1   10 , Valeria Meroni  11
Affiliations
Observational Study

Risk of Congenital Toxoplasmosis in Newborns from Mothers with Documented Infection: Experience from Two Referral Centres

Alice Bonetti et al. Pathogens. .

Abstract

During pregnancy, primary Toxoplasma gondii infection can cause congenital toxoplasmosis (CT). We described the newborns' outcomes from a multicentre cohort of mothers with seroconversion (SC) at different gestational ages. This retrospective observational study (from 2007 to 2018) was conducted in two Italian referral hospitals: Fondazione IRCCS Policlinico San Matteo in Pavia and Spedali Civili in Brescia. In total, 247 pregnant women were enrolled: seroconversions were enrolled: seroconversions documented as having occurred in the two months preceding pregnancy in 12 cases (4.9%; 95% CI 2.2-7.5%), and during pregnancy in 235 cases (95.1%; 95% CI 92.5-97.8%). SC is defined as the appearance of specific anti-Toxoplasma antibodies (IgM/IgG) during pregnancy in a previously seronegative woman. A total of 56 (22.5%; 95% CI 17.3-27.7%) newborns were lost to follow-up; thus, the outcome of 193 (77.5%; 95% CI 72.3-82.7%) newborns was analyzed. The overall transmission rate of T. gondii infection was 23.8% (95% CI 17.8-29.8%), 0% (95% CI 0.0-11.9%) among the 1st trimester SCs, 12.5% (95% CI 5.6-19.4%) among the 2nd trimester SCs, 53.8% (95% CI 41.7-66.0%) among the 3rd trimester ones. No CT were found in the group of periconceptional infection. Among the infected newborns, clinically manifest cases were 12 (26.1%; 95% CI 13.4-38.8%), including 1 case (2.2%; 95% CI 2.0-6.4%) of stillbirth and 11 symptomatic neonates (23.9%; 95% CI 11.6-36.2%). A total of 83 amniocentesis were performed (33.6%; 95% CI 27.7-39.5%), no complication was recorded and no false positive or false negative results were registered. The results are in line with the fetal risks reported in literature for T. gondii infection during pregnancy, even if at a lower percentage probably due to a prompt treatment.

Keywords: Toxoplasma gondii; amniocentesis; pyrimethamine; spiramycin; sulfadiazine; toxoplasmosis in pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Vertical transmission rate related to time of maternal infection.
Figure 2
Figure 2
Symptomatic and asymptomatic infected newborns in relation to time of maternal infection.
See this image and copyright information in PMC

References

    1. Robert-Gangneux F., Dardé M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 2012;25:264–296. doi: 10.1128/CMR.05013-11. - DOI - PMC - PubMed
    1. Hill D., Dubey J.P. Toxoplasma gondii: Transmission, diagnosis and prevention. Clin. Microbiol. Infect. 2002;8:634–640. doi: 10.1046/j.1469-0691.2002.00485.x. - DOI - PubMed
    1. Peyron F., L’ollivier C., Mandelbrot L., Wallon M., Piarroux R., Kieffer F., Hadjadj E., Paris L., Garcia-Meric P. Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens. 2019;8:24. doi: 10.3390/pathogens8010024. - DOI - PMC - PubMed
    1. Tomasoni L., Messina G., Genco F., Scudeller L., Prestia M., Spinoni V., Bonfanti C., Prefumo F., Castelli F., Meroni V. Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: An observational retrospective study. Clin. Microbiol. Infect. 2018;25:761.e9–761.e13. doi: 10.1016/j.cmi.2018.09.024. - DOI - PubMed
    1. Wallon M., Peyron F., Cornu C., Vinault S., Abrahamowicz M., Kopp C.B., Binquet C. Congenital Toxoplasma Infection: Monthly Prenatal Screening Decreases Transmission Rate and Improves Clinical Outcome at Age 3 Years. Clin. Infect. Dis. 2013;56:1223–1231. doi: 10.1093/cid/cit032. - DOI - PubMed

Publication types

LinkOut - more resources